SAFETY AND IMMUNOGENICITY IN CHILDREN AND ADULTS FROM ENDEMIC COUNTRIES AND ADULTS FROM NONENDEMIC COUNTRIES OF A TETRAVALENT, LIVE ATTENUATED DENGUE VACCINE

被引：0
|
作者：
Bouckenooghe, Alain [1 ]
Capeding, Maria R. [2 ]
Morrison, Dennis N. [3 ]
Poo, Jorge L. [4 ]
Lang, Jean [5 ]
Chambonneau, Laurent [5 ]
Forrat, Remi [5 ]
机构：
[1] Sanofi Pasteur, Swiftwater, PA USA
[2] Res Inst Trop Med, Muntinlupa, Philippines
[3] Biokinet Clin Applicat, Springfield, MO USA
[4] Hosp Med Sur, Mexico City, DF, Mexico
[5] Sanofi Pasteur, Marcy Letoile, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2008年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
386
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
    Block, Stan L.
    Falloon, Judith
    Hirschfield, Jeffrey A.
    Krilov, Leonard R.
    Dubovsky, Filip
    Yi, Tingting
    Belshe, Robert B.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (07) : 745 - 751
  • [32] Safety and immunogenicity of a single dose, live-attenuated 'tetravalent dengue vaccine' in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
    Mohanty, Lalitendu
    Prabhu, Madhav
    Mishra, Amit Kumar
    Purty, Anil J.
    Kanungo, Reba
    Ghosh, Goutam
    Kumar, R. Prahan
    Raj, A. Newton
    Bhushan, Sumit
    Jangir, Manoj Kumar
    Gupta, Anu
    Bhakri, Anju
    VACCINE: X, 2022, 10
  • [33] A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
    Thomas, Stephen J.
    Eckels, Kenneth H.
    Carletti, Isabelle
    De La Barrera, Rafael
    Dessy, Francis
    Fernandez, Stefan
    Putnak, Robert
    Toussaint, Jean-Francois
    Sun, Wellington
    Bauer, Kristen
    Gibbons, Robert V.
    Innis, Bruce L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 88 (01): : 73 - 88
  • [34] A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country
    Tricou, Vianney
    Eyre, Susannah
    Ramjee, Mahadev
    Mojares, Zenaida
    Collini, Paul
    Loeliger, Edde
    Mandaric, Sanja
    Rauschera, Martina
    Brose, Manja
    Lefevre, Inge
    Folschweiller, Nicolas
    Wallace, Derek
    VACCINE, 2023, 41 (07) : 1398 - 1407
  • [35] Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
    Jongo, Said A.
    Nchama, Vicente Urbano Nsue Ndong
    Church, L. W. Preston
    Olotu, Ally
    Manock, Stephen R.
    Schindler, Tobias
    Mtoro, Ali
    Natasha, K. C.
    Devinsky, Orrin
    Zan, Elcin
    Hamad, Ali
    Nyakarungu, Elizabeth
    Mpina, Maxmillian
    Deal, Anna
    Bijeri, Jose Raso
    Mangue, Martin Eka Ondo
    Pasialo, Beltran Ekua Ntutumu
    Nguema, Genaro Nsue
    Rivas, Matilde Riloha
    Chemba, Mwajuma
    Ramadhani, Kamaka K.
    James, Eric R.
    Stabler, Thomas C.
    Abebe, Yonas
    Riyahi, Pouria
    Saverino, Elizabeth S.
    Sax, Julian
    Hosch, Salome
    Tumbo, Anneth
    Gondwe, Linda
    Segura, J. Luis
    Falla, Carlos Cortes
    Phiri, Wonder Philip
    Hergott, Dianna E. B.
    Garcia, Guillermo A.
    Maas, Carl
    Murshedkar, Tooba
    Billingsley, Peter F.
    Tanner, Marcel
    Ayekaba, Mitoha Ondo'o
    Sim, B. Kim Lee
    Daubenberger, Claudia
    Richie, Thomas L.
    Abdulla, Salim
    Hoffman, Stephen L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 109 (01): : 138 - 146
  • [36] Impact of Obesity and Being Overweight on the Immunogenicity to Live Attenuated Hepatitis A Vaccine in Children and Young Adults
    Dumrisilp, Termpong
    Wongpiyabovorn, Jongkonnee
    Buranapraditkun, Supranee
    Tubjaroen, Chomchanat
    Chaijitraruch, Nataruks
    Prachuapthunyachart, Sittichoke
    Sintusek, Palittiya
    Chongsrisawat, Voranush
    VACCINES, 2021, 9 (02) : 1 - 11
  • [37] Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials
    Gailhardou, Sophia
    Skipetrova, Anna
    Dayan, Gustavo H.
    Jezorwski, John
    Saville, Melanie
    Van der Vliet, Diane
    Wartel, T. Anh
    PLOS NEGLECTED TROPICAL DISEASES, 2016, 10 (07):
  • [38] Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
    Halstead, Scott B.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) : 2158 - 2162
  • [39] EVALUATION OF LIVE ATTENUATED INFLUENZA VACCINE SAFETY AND IMMUNOGENICITY IN CHILDREN WITH ASTHMA
    GRUBER, WC
    GRUBER, RA
    TATE, SM
    SANDERS, DS
    WRIGHT, PF
    PEDIATRIC RESEARCH, 1995, 37 (04) : A176 - A176
  • [40] Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults
    Weinberg, Adriana
    Levin, Myron J.
    MacGregor, Rob Roy
    HUMAN VACCINES, 2010, 6 (04): : 318 - 321
12345